Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1979 1
1980 13
1981 2
1982 6
1983 3
1984 1
1985 7
1986 4
1987 13
1988 13
1989 15
1990 12
1991 13
1992 17
1993 16
1994 22
1995 23
1996 14
1997 26
1998 28
1999 31
2000 47
2001 43
2002 46
2003 66
2004 82
2005 121
2006 113
2007 119
2008 145
2009 146
2010 221
2011 202
2012 241
2013 311
2014 374
2015 425
2016 430
2017 528
2018 568
2019 792
2020 925
2021 1148
2022 1368
2023 1340
2024 1579
2025 1419
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,764 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial.
Rha SY, Oh DY, Yañez P, Bai Y, Ryu MH, Lee J, Rivera F, Alves GV, Garrido M, Shiu KK, Fernández MG, Li J, Lowery MA, Çil T, Cruz FM, Qin S, Luo S, Pan H, Wainberg ZA, Yin L, Bordia S, Bhagia P, Wyrwicz LS; KEYNOTE-859 investigators. Rha SY, et al. Among authors: luo s. Lancet Oncol. 2023 Nov;24(11):1181-1195. doi: 10.1016/S1470-2045(23)00515-6. Epub 2023 Oct 21. Lancet Oncol. 2023. PMID: 37875143 Clinical Trial.
SGLT2 inhibitor promotes ketogenesis to improve MASH by suppressing CD8+ T cell activation.
Liu W, You D, Lin J, Zou H, Zhang L, Luo S, Yuan Y, Wang Z, Qi J, Wang W, Ye X, Yang X, Deng Y, Teng F, Zheng X, Lin Y, Huang Z, Huang Y, Yang Z, Zhou X, Zhang Y, Chen R, Xu L, Li J, Yang W, Zhang H. Liu W, et al. Among authors: luo s. Cell Metab. 2024 Oct 1;36(10):2245-2261.e6. doi: 10.1016/j.cmet.2024.08.005. Epub 2024 Sep 6. Cell Metab. 2024. PMID: 39243758
OXCT1 succinylation and activation by SUCLA2 promotes ketolysis and liver tumor growth.
Guo D, Yu Q, Tong Y, Qian X, Meng Y, Ye F, Jiang X, Wu L, Yang Q, Li S, Li M, Wu Q, Xiao L, He X, Zhu R, Liu G, Nie D, Luo S, Ma L, Jin RA, Liu Z, Liang X, Yan D, Lu Z. Guo D, et al. Among authors: luo s. Mol Cell. 2025 Feb 20;85(4):843-856.e6. doi: 10.1016/j.molcel.2024.12.025. Epub 2025 Jan 24. Mol Cell. 2025. PMID: 39862868
Cohort Profile: South China Cohort.
Yang J, Luo S, Liu Y, Hong M, Qiu X, Lin Y, Zhang W, Gao P, Li Z, Hu Z, Xia M; South China Cohort (SCC) Collaborative Group. Yang J, et al. Among authors: luo s. Int J Epidemiol. 2024 Feb 14;53(2):dyae028. doi: 10.1093/ije/dyae028. Int J Epidemiol. 2024. PMID: 38412541 No abstract available.
11,764 results
You have reached the last available page of results. Please see the User Guide for more information.